| HSD17B10 | 17-beta-hydroxysteroid dehydrogenase X deficiency | 300438 |
| ACADSB | 2-methylbutyrylglycinuria | 610006 |
| MCCC1 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | 210200 |
| MCCC2 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | 210210 |
| FGD1 | Aarskog-Scott syndrome; Mental retardation, X-linked 16 | 305400 |
| SLC26A2 | Achondrogenesis Ib | 600972 |
| CNGB3 | Achromatopsia-3 | 262300 |
| ACADM | Acyl-CoA dehydrogenase, medium chain, deficiency of | 201450 |
| ACADS | Acyl-CoA dehydrogenase, short-chain, deficiency of | 201470 |
| CYP17A1 | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | 202110 |
| CYP21A2 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | 201910 |
| ABCD1 | Adrenoleukodystrophy | 300100 |
| HGD | Alkaptonuria | 203500 |
| SLC16A2 | Allan-Herndon-Dudley syndrome | 300523 |
| ACAT1 | Alpha-methylacetoacetic aciduria | 203750 |
| ATRX | Alpha-thalassemia/mental retardation syndrome | 301040 |
| COL4A4 | Alport syndrome, autosomal recessive | 203780 |
| RMRP | Anauxetic dysplasia | 607095 |
| AR | Androgen insensitivity | 300068 |
| ARG1 | Argininemia | 207800 |
| ASL | Argininosuccinic aciduria | 207900 |
| PRPS1 | Arts syndrome | 301835 |
| AGA | Aspartylglucosaminuria | 208400 |
| TTPA | Ataxia with isolated vitamin E deficiency | 277460 |
| ATM | Ataxia-telangiectasia | 208900 |
| OTOF | Auditory neuropathy, autosomal recessive, 1 | 601071 |
| AIRE | Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia | 240300 |
| BBS1 | Bardet-Biedl syndrome 1 | 209900 |
| BBS10 | Bardet-Biedl syndrome 10 | 615987 |
| CEP290 | Bardet-Biedl syndrome 14; Joubert syndrome 5; Meckel syndrome 4; Senior-Loken syndrome 6 | 615991; 610188; 611134; 610189 |
| BBS2 | Bardet-Biedl syndrome 2 | 615981 |
| BSND | Bartter syndrome, type 4a | 602522 |
| DMD | Duchenne muscular dystrophy; Becker muscular dystrophy | 310200; 300376 |
| BTD | Biotinidase deficiency | 253260 |
| BCS1L | Bjornstad syndrome | 262000 |
| ASPA | Canavan disease | 271900 |
| CPS1 | Carbamoylphosphate synthetase I deficiency | 237300 |
| SLC22A5 | Carnitine deficiency, systemic primary | 212140 |
| SLC25A20 | Carnitine-acylcarnitine translocase deficiency | 212138 |
| CYP27A1 | Cerebrotendinous xanthomatosis | 213700 |
| PPT1 | Ceroid lipofuscinosis, neuronal, 1 | 256730 |
| CTSD | Ceroid lipofuscinosis, neuronal, 10 | 610127 |
| TPP1 | Ceroid lipofuscinosis, neuronal, 2 | 204500 |
| CLN3 | Ceroid lipofuscinosis, neuronal, 3 | 204200 |
| CLN5 | Ceroid lipofuscinosis, neuronal, 5 | 256731 |
| CLN6 | Ceroid lipofuscinosis, neuronal, 6 | 601780 |
| MFSD8 | Ceroid lipofuscinosis, neuronal, 7 | 610951 |
| CLN8 | Ceroid lipofuscinosis, neuronal, 8 | 600143 |
| MTMR2 | Charcot-Marie-Tooth disease, type 4B1 | 601382 |
| SH3TC2 | Charcot-Marie-Tooth disease, type 4C | 601596 |
| NDRG1 | Charcot-Marie-Tooth disease, type 4D | 601455 |
| GDAP1 | Charcot-Marie-Tooth Neuropathy Type 4A | 214400 |
| ABCB11 | Cholestasis, benign recurrent intrahepatic, 2 | 601847 |
| ARSF | Chondrodysplasia punctata, X-linked recessive | 302950 |
| ARSE | Chondrodysplasia punctata, X-linked recessive | 302950 |
| ASS1 | Citrullinemia | 215700 |
| SLC25A13 | Citrullinemia, adult-onset type II; type II, neonatal-onset | 603471; 605814 |
| RPS6KA3 | Coffin-Lowry syndrome | 303600 |
| ACSF3 | Combined malonic and methylmalonic acidemia | 614265 |
| ABCA4 | Cone-rod dystrophy 3 | 604116 |
| AIPL1 | Cone-rod dystrophy, 604393 (Congenital Leber Amaurosis, 4) | 604393 |
| RPGR | Cone-rod dystrophy, X-linked, 1 | 304020 |
| PMM2 | Congenital disorder of glycosylation, type Ia | 212065 |
| SLC4A11 | Corneal dystrophy, Fuchs endothelial, 4 | 613268 |
| CPT1A | CPT deficiency, hepatic, type IA | 255120 |
| CPT2 | CPT II deficiency, lethal neonatal | 608836 |
| CTH | Cystathioninuria | 219500 |
| CFTR | Cystic Fibrosis; Congenital bilateral absence of vas deferens | 219700; 277180 |
| CTNS | Cystinosis, atypical nephropathic | 219800 |
| SLC3A1 | Cystinuria | 220100 |
| SLC7A9 | Cystinuria | 220100 |
| CDH23 | Deafness, autosomal recessive 12 | 601386 |
| USH1C | Deafness, autosomal recessive 18A | 602092 |
| GJB2 | Deafness, autosoma recessive 1A; DFNB1A | 220290 |
| PCDH15 | Deafness, autosomal recessive 23 | 609533 |
| SLC26A4 | Deafness, autosomal recessive 4, with enlarged vestibular aqueduct | 600791 |
| GJB3 | Deafness, digenic, GJB2/GJB3 | 220290 |
| POU3F4 | Deafness, X-linked 2 | 304400 |
| OCRL | Dent disease 2 | 300555 |
| DLD | Dihydrolipoamide dehydrogenase deficiency | 246900 |
| F2 | Dysprothrombinemia | 613679 |
| COL7A1 | EBD inversa | 226600 |
| PLOD1 | Ehlers-Danlos syndrome, type VI | 225400 |
| EVC2 | Ellis-van Creveld syndrome | 225500 |
| SERPINA1 | Emphysema due to AAT deficiency | 613490 |
| LAMB3 | Epidermolysis bullosa, junctional, Herlitz type; non-Herlitz type | 226700; 226650 |
| LAMC2 | Epidermolysis bullosa, junctional, Herlitz type; non-Herlitz type | 226700; 226650 |
| SYN1 | Epilepsy, X-linked, with variable learning disabilities and behavior disorders | 300491 |
| ARX | Epileptic encephalopathy, early infantile, 1 | 308350 |
| ETHE1 | Ethylmalonic encephalopathy | 602473 |
| GLA | Fabry disease | 301500 |
| F5 | Factor V deficiency | 227400 |
| F11 | Factor XI deficiency, autosomal dominant & recessive | 612416 |
| MEFV | Familial Mediterranean fever, AR | 249100 |
| FANCA | Fanconi anemia | 227650 |
| FANCC | Fanconi anemia, complementation group C | 227645 |
| G6PD | Favism | 134700 |
| SLC46A1 | Folate malabsorption, hereditary | 229050 |
| FMR1 | Fragile X syndrome | 300624 |
| FXN | Friedreich ataxia with retained reflexes | 229300 |
| ALDOB | Fructose intolerance | 229600 |
| FH | Fumarase deficiency | 606812 |
| GALK1 | Galactokinase deficiency with cataracts | 230200 |
| GALE | Galactose epimerase deficiency | 230350 |
| GALT | Galactosemia | 230400 |
| GBA | Gaucher disease, perinatal lethal | 608013 |
| FTCD | Glutamate formiminotransferase deficiency | 229100 |
| ETFA | Glutaric acidemia IIA | 231680 |
| ETFB | Glutaric acidemia IIB | 231680 |
| ETFDH | Glutaric acidemia IIC | 231680 |
| GCDH | Glutaricaciduria, type I | 231670 |
| GLDC | Glycine encephalopathy | 605899 |
| AMT | Glycine encephalopathy | 605899 |
| GNMT | Glycine N-methyltransferase deficiency | 606664 |
| G6PC | Glycogen storage disease Ia | 232200 |
| SLC37A4 | Glycogen storage disease Ib | 232220 |
| GAA | Glycogen storage disease II / Pompe Disease | 232300 |
| AGL | Glycogen storage disease IIIa | 232400 |
| GBE1 | Glycogen storage disease IV | 232500 |
| GLB1 | GM1-gangliosidosis, types I, II and III | 230500; 230600; 230650 |
| NR2E3 | Goldmann-Favre syndrome | 268100 |
| PANK2 | HARP syndrome | 607236 |
| SLC6A19 | Hartnup disorder | 234500 |
| PEX6 | Heimler syndrome, type 2 | 616617 |
| TFR2 | Hemochromatosis, type 3 | 604250 |
| HFE2 | Hemochromatosis: Type 2A; HFE2 Related | 602390 |
| F8 | Hemophilia A | 306700 |
| F9 | Hemophilia B | 306900 |
| HAL | Histidinemia | 235800 |
| HMGCL | HMG-CoA lyase deficiency | 246450 |
| HLCS | Holocarboxylase synthetase deficiency | 253270 |
| MTHFR | Homocystinuria due to MTHFR deficiency | 236250 |
| MTRR | Homocystinuria-megaloblastic anemia, cbl E type | 236270 |
| CBS | Homocystinuria, B6-responsive and nonresponsive types | 236200 |
| MMADHC | Homocystinuria, cblD type, variant 1 / Methylmalonic aciduria and homocystinuria, cblD type / Methylmalonic aciduria, cblD type, variant 2 | 277410 |
| MVK | Hyper-IgD syndrome; Mevalonic aciduria | 260920; 610377 |
| LDLR | Hypercholesterolemia, familial | 143890 |
| LDLRAP1 | Hypercholesterolemia, familial, autosomal recessive | 603813 |
| KCNJ11 | Hyperinsulinemic hypoglycemia, familial, Type 2 | 601820 |
| ADK | Hypermethioninemia due to adenosine kinase deficiency | 614300 |
| AHCY | Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase | 613752 |
| MAT1A | Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency | 250850 |
| AGXT | Hyperoxaluria, primary, type 1 | 259900 |
| GRHPR | Hyperoxaluria, primary, type II | 260000 |
| HOGA1 | Hyperoxaluria, primary, type III | 613616 |
| PTS | Hyperphenylalaninemia, BH4-deficient, A | 261640 |
| QDPR | Hyperphenylalaninemia, BH4-deficient, C | 261630 |
| PCBD1 | Hyperphenylalaninemia, BH4-deficient, D | 264070 |
| ALDH4A1 | Hyperprolinemia, type II | 239510 |
| TSHR | Hyperthyroidism, familial gestational; Hypothyroidism, congenital, nongoitrous, 1 | 603373; 275200 |
| GNRHR | Hypogonadotropic hypogonadism 7 without anosmia | 146110 |
| TSHB | Hypothryoidism, congenital, nongoitrous 4 | 275100 |
| PAX8 | Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia | 218700 |
| TGM1 | Ichthyosis, congenital, autosomal recessive 1 | 242300 |
| CD40LG | Immunodeficiency, X-linked, with hyper-IgM | 308230 |
| IVD | Isovaleric acidemia | 243500 |
| TMEM216 | Joubert syndrome 2 | 608091 |
| AHI1 | Joubert syndrome 3 | 608629 |
| NPHP1 | Joubert syndrome 4 | 609583 |
| ARL13B | Joubert syndrome 8 | 612291 |
| GALC | Krabbe disease | 245200 |
| HADHA | LCHAD deficiency | 609016 |
| GUCY2D | Leber congenital amaurosis | 204000 |
| RDH12 | Leber congenital amaurosis 13 | 612712 |
| RPE65 | Leber congenital amaurosis 2 | 204100 |
| CRB1 | Leber congenital amaurosis 8 | 613835 |
| SURF1 | Leigh syndrome, due to COX deficiency | 256000 |
| LRPPRC | Leigh syndrome, French-Canadian type | 220111 |
| DYSF | limb-girdle muscular dystrophy type 2B | 253601 |
| STAR | Lipoid adrenal hyperplasia | 201710 |
| DCX | Lissencephaly, X-linked | 300067 |
| CHST6 | Macular corneal dystrophy | 217800 |
| MLYCD | Malonyl-CoA decarboxylase deficiency | 248360 |
| MAN2B1 | Mannosidosis, alpha-, types I and II | 248500 |
| BCKDHA | Maple syrup urine disease, type Ia | 248600 |
| BCKDHB | Maple syrup urine disease, type Ib | 248600 |
| DBT | Maple syrup urine disease, type II | 248600 |
| L1CAM | MASA syndrome / CRASH syndrome | 303350 |
| PYGM | McArdle disease | 232600 |
| MKS1 | Meckel syndrome 1 | 249000 |
| CASK | Mental retardation and microcephaly with pontine and cerebellar hypoplasia | 300749 |
| PHF8 | Mental retardation syndrome, X-linked, Siderius type | 300263 |
| OPHN1 | Mental retardation, X-linked | 300486 |
| IQSEC2 | Mental retardation, X-linked 1/78 | 309530 |
| THOC2 | Mental retardation, X-linked 12/35 | 300957 |
| IL1RAPL1 | Mental retardation, X-linked 21/34 | 300143 |
| PAK3 | Mental retardation, X-linked 30/47 | 300558 |
| GDI1 | Mental retardation, X-linked 41 | 300849 |
| TSPAN7 | Mental retardation, X-linked 58 | 300210 |
| ACSL4 | Mental retardation, X-linked 63 | 300387 |
| FTSJ1 | Mental retardation, X-linked 9 | 309549 |
| DLG3 | Mental retardation, X-linked 90 | 300850 |
| GRIA3 | Mental retardation, X-linked 94 | 300699 |
| ZNF711 | Mental retardation, X-linked 97 | 300803 |
| USP9X | Mental retardation, X-linked 99 | 300919 |
| AP1S2 | Mental retardation, X-linked syndromic 5 | 304340 |
| ZDHHC9 | Mental retardation, X-linked syndromic, Raymond type | 300799 |
| HUWE1 | Mental retardation, X-linked syndromic, Turner type | 300706 |
| NLGN4X | Mental retardation, X-linked, Asperger syndrome susceptibility, X-linked | 300427 |
| AFF2 | Mental retardation, X-linked, FRAXE type | 309548 |
| MECP2 | Mental retardation, X-linked, syndromic 13 | 300055 |
| UPF3B | Mental retardation, X-linked, syndromic 14 | 300676 |
| CUL4B | Mental retardation, X-linked, syndromic 15 | 300354 |
| KDM5C | Mental retardation, X-linked, syndromic, Claes-Jensen type | 300534 |
| ARSA | Metachromatic leukodystrophy | 250100 |
| MMACHC | Methylmalonic aciduria and homocystinuria, cblC type | 277400 |
| LMBRD1 | Methylmalonic aciduria and homocystinuria, cblF type | 277380 |
| ABCD4 | Methylmalonic aciduria and homocystinuria, cblJ type | 614857 |
| MUT | Methylmalonic aciduria, mut(0) type | 251000 |
| MMAA | Methylmalonic aciduria, vitamin B12-responsive | 251100 |
| MMAB | Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type | 251110 |
| MCEE | Methylmalonyl-CoA epimerase deficiency | 251120 |
| RAX | Microphthalmia, isolated 3 | 611038 |
| GNPTAB | Mucolipidosis II and III, alpha/beta | 252500; 252600 |
| MCOLN1 | Mucolipidosis IV | 252650 |
| SGSH | Mucopolysaccharidisis type IIIA (Sanfilippo A) | 252900 |
| IDUA | Mucopolysaccharidosis Ih | 607014 |
| IDS | Mucopolysaccharidosis II | 309900 |
| GALNS | Mucopolysaccharidosis IVA | 253000 |
| NAGLU | Mucopolysaccharidosis type IIIB (Sanfilippo B) | 252920 |
| HGSNAT | Mucopolysaccharidosis type IIIC (Sanfilippo C) | 252930 |
| GNS | Mucopolysaccharidosis type IIID | 252940 |
| ARSB | Mucopolysaccharidosis type VI (Maroteaux-Lamy) | 253200 |
| POMT1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | 236670 |
| POMT2 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 | 613150 |
| POMGNT1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3 | 253280 |
| FKRP | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5 | 613153 |
| CAPN3 | Muscular dystrophy, limb-girdle, type 2A | 253600 |
| SGCA | Muscular dystrophy, limb-girdle, type 2D | 608099 |
| SGCB | Muscular dystrophy, limb-girdle, type 2E | 604286 |
| CLCN1 | Myotonia congenita, dominant; recessive | 160800; 255700 |
| NEB | Nemaline myopathy 2, autosomal recessive | 256030 |
| NPHS1 | Nephrotic syndrome, type 1 | 256300 |
| HAX1 | Neutropenia, severe congenital 3, autosomal recessive | 610738 |
| SMPD1 | Niemann-Pick disease, type A | 257200 |
| NPC1 | Niemann-Pick disease, type C1 | 257220 |
| NPC2 | Niemann-pick disease, type C2 | 607625 |
| NBN | Nijmegen Breakage Syndrome (Ataxia telangectasia, type 1) | 251260 |
| NDP | Norrie disease | 310600 |
| GPR143 | Nystagmus 6, congenital, X-linked | 300814 |
| OTC | Ornithine transcarbamylase deficiency | 311250 |
| P3H1 | Osteogenesis imperfecta, type VIII | 610915 |
| PLP1 | Pelizaeus-Merzbacher disease | 312080 |
| ACOX1 | Peroxisomal acyl-CoA oxidase deficiency | 264470 |
| PEX1 | Peroxisome biogenesis disorder 1A (Zellweger) | 214100 |
| PEX10 | Peroxisome biogenesis disorder 6A (Zellweger) | 614870 |
| PEX7 | Peroxisome biogenesis disorder 9B; Rhizomelic chondroplasia punctata, type I | 614879; 215100 |
| PAH | Phenylketonuria | 261600 |
| PGK1 | Phosphoglycerate kinase 1 deficiency | 300653 |
| PROP1 | Pituitary hormone deficiency, combined, 2 | 262600 |
| PKHD1 | Polycystic kidney and hepatic disease | 263200 |
| DNAH5 | Primary ciliary dyskinesia | 608644 |
| PCCA | Propionic acidemia | 606054 |
| PCCB | Propionic acidemia | 606054 |
| PC | Pyruvate carboxylase deficiency | 266150 |
| PDHB | Pyruvate dehydrogenase E1-beta deficiency | 614111 |
| PQBP1 | Renpenning syndrome | 309500 |
| RP2 | Retinitis pigmentosa 2 | 312600 |
| EYS | Retinitis pigmentosa 25 | 602772 |
| CERKL | Retinitis pigmentosa 26 | 608380 |
| USH2A | Retinitis pigmentosa 39 | 613809 |
| PDE6A | Retinitis pigmentosa 43 | 613810 |
| CNGB1 | Retinitis pigmentosa 45 | 613767 |
| IDH3B | Retinitis pigmentosa 46 | 612572 |
| CNGA1 | Retinitis pigmentosa 49 | 613756 |
| DHDDS | Retinitis pigmentosa 59 | 613861 |
| RS1 | Retinoschisis | 312700 |
| AGPS | Rhizomelic chondrodysplasia punctata, type 3 | 600121 |
| HEXB | Sandhoff disease, infantile, juvenile, and adult forms | 268800 |
| JAK3 | SCID, autosomal recessive, T-negative/B-positive type | 600802 |
| TH | Segawa syndrome, recessive | 605407 |
| ADA | Severe combined immunodeficiency due to ADA deficiency | 102700 |
| IL2RG | Severe combined immunodeficiency, X-linked | 300400 |
| DHCR7 | Smith-Lemli-Opitz syndrome | 270400 |
| SACS | Spastic ataxia, Charlevoix-Saguenay type | 270550 |
| SPG11 | Spastic paraplegia 11, autosomal recessive | 604360 |
| SPG7 | Spastic paraplegia 7, autosomal recessive | 607259 |
| SMN1 | Spinal muscular atrophy, type I | 253300 |
| HEXA | Tay-Sachs; GM2-gangliosidosis, several forms | 272800 |
| HBB | Thalassemia, beta | 613985 |
| HBA1 | Thalassemias, alpha- | 604131 |
| HBA2 | Thalassemias, alpha- | 604131 |
| MPL | Thrombocytopenia, congenital amegakaryocytic | 604498 |
| DUOX2 | Thryoid dyshormonogenesis 6 | 607200 |
| SLC5A5 | Thyroid dyshormonogenesis 1 | 274400 |
| TPO | Thyroid dyshormonogenesis 2A | 274500 |
| TG | Thyroid dyshormonogenesis 3 | 274700 |
| IYD | Thyroid dyshormonogenesis 4 | 274800 |
| DUOXA2 | Thyroid dyshormonogenesis 5 | 274900 |
| THRB | Thyroid hormone resistance | 274700 |
| POLR1C | Treacher Collins syndrome 3 | 248390 |
| HADHB | Trifunctional protein deficiency | 609015 |
| FAH | Tyrosinemia, type I | 276700 |
| TAT | Tyrosinemia, type II | 276600 |
| MYO7A | Usher syndrome, type 1B; Deafness, autosomal dominant 11 | 276900; 601317 |
| USH1G | Usher syndrome, type 1G | 606943 |
| WHRN | Usher syndrome, type 2D / Deafness, autosomal recessive 31 | 611383 |
| CLRN1 | Usher syndrome, type 3A | 276902 |
| CASQ2 | Ventricular tachycardia, catecholaminergic polymorphic, 2 | 611938 |
| TRDN | Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness | 615441 |
| ACADVL | VLCAD deficiency | 201475 |
| FKTN | Walker-Warburg syndrome, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 | 253800 |
| ATP7B | Wilson disease | 277900 |
| LIPA | Wolman disease (lysosomal acid lipase deficiency) | 278000 |
| BRWD3 | X-linked mental retardation (XLMR) associated with macrocephaly | 300659 |